Covenant Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,665
| Closed | -$401K | – | 108 |
|
|
2025
Q4 | $401K | Hold |
1,665
| – | – | 0.12% | 81 |
|
|
2025
Q3 | $456K | Hold |
1,665
| – | – | 0.13% | 75 |
|
|
2025
Q2 | $430K | Hold |
1,665
| – | – | 0.13% | 81 |
|
|
2025
Q1 | $373K | Sell |
1,665
-990
| -37% | -$231K | 0.12% | 87 |
|
|
2024
Q4 | $607K | Sell |
2,655
-25
| -0.9% | -$6.02K | 0.19% | 65 |
|
|
2024
Q3 | $654K | Buy |
2,680
+25
| +0.9% | +$5.59K | 0.19% | 72 |
|
|
2024
Q2 | $508K | Hold |
2,655
| – | – | 0.15% | 91 |
|
|
2024
Q1 | $526K | Sell |
2,655
-2,014
| -43% | -$369K | 0.15% | 95 |
|
|
2023
Q4 | $803K | Hold |
4,669
| – | – | 0.25% | 60 |
|
|
2023
Q3 | $690K | Hold |
4,669
| – | – | 0.25% | 65 |
|
|
2023
Q2 | $1.02M | Hold |
4,669
| – | – | 0.37% | 39 |
|
|
2023
Q1 | $1.02M | Sell |
4,669
-1,800
| -28% | -$391K | 0.39% | 36 |
|
|
2022
Q4 | $1.35M | Hold |
6,469
| – | – | 0.54% | 24 |
|
|
2022
Q3 | $1.41M | Sell |
6,469
-864
| -12% | -$197K | 0.69% | 19 |
|
|
2022
Q2 | $1.54M | Buy |
7,333
+781
| +12% | +$166K | 0.71% | 19 |
|
|
2022
Q1 | $1.59M | Sell |
6,552
-584
| -8% | -$141K | 0.63% | 20 |
|
|
2021
Q4 | $1.86M | Hold |
7,136
| – | – | 0.69% | 20 |
|
|
2021
Q3 | $1.88M | Hold |
7,136
| – | – | 0.74% | 19 |
|
|
2021
Q2 | $1.76M | Hold |
7,136
| – | – | 0.66% | 20 |
|
|
2021
Q1 | $1.39M | Sell |
7,136
-1,583
| -18% | -$317K | 0.55% | 26 |
|
|
2020
Q4 | $1.85M | Buy |
8,719
+609
| +8% | +$121K | 0.78% | 19 |
|
|
2020
Q3 | $1.39M | Sell |
8,110
-2,153
| -21% | -$398K | 0.67% | 19 |
|
|
2020
Q2 | $1.97M | Hold |
10,263
| – | – | 0.91% | 16 |
|
|
2020
Q1 | $1.51M | Sell |
10,263
-382
| -4% | -$60.8K | 0.81% | 17 |
|
|
2019
Q4 | $1.65M | Hold |
10,645
| – | – | 0.77% | 18 |
|
|
2019
Q3 | $1.44M | Hold |
10,645
| – | – | 0.76% | 18 |
|
|
2019
Q2 | $1.3M | Sell |
10,645
-2,788
| -21% | -$309K | 0.69% | 23 |
|
|
2019
Q1 | $1.4M | Buy |
13,433
+5,133
| +62% | +$530K | 0.78% | 14 |
|
|
2018
Q4 | $945K | Buy |
+8,300
| New | +$889K | 0.45% | 16 |
|
Other funds holding RMD
VCM
VPM
DAM
Covenant Partners's RMD Position: Q1 2026 in Review
Covenant Partners sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,665 shares — an estimated $401K sold.
Covenant Partners first reported a position in RMD in Q4 2018 and held it in 29 quarters. The position peaked at $1.97M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Covenant Partners reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
- Covenant Partners sold 1,665 ResMed shares in Q1 2026, an estimated $401K.
- Covenant Partners first reported a position in ResMed in Q4 2018 and held it in 29 quarters.
- Covenant Partners's ResMed position peaked at $1.97M in Q2 2020.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Covenant Partners's 13F filing for Q1 2026.